Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be older than 6 months of age.
- Your leukemia (AML) cells must have been tested and confirmed to carry certain markers called CLL-1, CD123, and/or CD33, found through a lab test or bone marrow/blood analysis.
- You must be in reasonably good general health, able to carry out normal activity with only minor difficulty, and expected to live longer than 3 months (confirm with trial site).
- Your heart, liver, and kidneys must be functioning well enough to meet specific lab test thresholds set by the trial team.
- Your hemoglobin (a measure of red blood cells) must be at or above a minimum level set by the trial (confirm with trial site for exact value).
- You must not have any medical reason that would prevent a cell collection procedure.
- You must be able to understand the trial and be willing to sign a written consent form agreeing to take part.
Who may not be able to join:
- People with a serious illness or uncontrolled infection that would make it unsafe to follow the trial plan.
- People with an active bacterial, fungal, or viral infection that is not being successfully treated.
- People who are known to have HIV, hepatitis B, or hepatitis C.
- Women who are pregnant or currently breastfeeding.
- People who have taken steroid medicines (such as corticosteroids) as a full-body treatment within the week before joining the trial.
- People who have previously received any gene therapy treatment.
- People who, in the trial doctors' judgement, may be unable to follow the trial requirements for any reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of infusion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.